Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial
在早期三阴性乳腺癌患者中，新辅助阿帕替尼联合信迪利单抗和卡铂-紫杉烷类化疗：NeoSAC II期试验
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02137-7
Shen, Guoshuang; Liu, Zhilin; Wang, Miaozhou; Zhao, Yi; Liu, Xinlan; Hou, Yujin; Ma, Wenbiao; Han, Jingqi; Zhou, Xiaofeng; Ren, Dengfeng; Zhao, Fuxing; Li, Zitao; Huang, Shifen; Chen, Yongzhi; He, Yingjian; Liu, Yan; Zhu, Zijun; Li, Yongxin; Li, Jinming; Da, Mengting; Mo, Hongnan; Du, Feng; Cui, Liang; Bai, Jing; Liu, Zhen; Ma, Fei; Zhao, Jiuda
